Intellia Therapeutics Inc (FRA:38I)
€ 21.68 -0.35 (-1.59%) Market Cap: 2.05 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.16 GF Score: 59/100

Q3 2020 Intellia Therapeutics Inc Earnings Call Transcript

Nov 05, 2020 / 01:00PM GMT
Release Date Price: €22.96 (+6.30%)
Operator

Good morning. My name is Drew, and I will be your conference operator today. And welcome to the Intellia Therapeutics Third Quarter 2020 Earnings Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. (Operator Instructions)

At this time, I would like to turn it over to Lina Li, Associate Director of Investor Relations at Intellia. Please proceed.

Lina Li
Intellia Therapeutics, Inc. - Associate Director of IR

Thank you, operator. Good morning, everyone, and welcome to Intellia's Third Quarter 2020 Earnings Call. Earlier today, we issued a press release outlining our progress this quarter and the topics we plan to discuss on today's call. This release can be found on the Investors and Media section of our website at intelliatx.com. This call is being broadcast live and a replay will also be archived on our website.

Before we get started, I would like to remind you that during this call we may make certain forward-looking statements and ask that you refer to our SEC filings

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot